Carbidopa/levodopa

DRUG6 trials

Sponsors

Institute for Neurodegenerative Disorders, Vanderbilt University, Novartis Pharmaceuticals, Northwestern University, New York State Psychiatric Institute

Conditions

Autonomic FailureCognitive ImpairmentDepressionDepressive DisorderGait ImpairmentOrthostatic HypotensionParkinson DiseaseParkinson's Disease

Phase 1

Treatment of Orthostatic Hypotension in Autonomic Failure

CompletedNCT00223691

Vanderbilt UniversityAutonomic Failure, Orthostatic Hypotension

Start: 2002-03-31End: 2017-01-31Updated: 2017-01-18

Phase 4

Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

WithdrawnNCT00601978

Novartis PharmaceuticalsParkinson's Disease

Start: 2008-08-31End: 2009-11-30Updated: 2012-04-30

Effect of L-dopa In Subacute Back Pain Population

CompletedNCT01951105

Northwestern UniversitySub-acute Back Pain

Start: 2015-02-24End: 2017-09-25Updated: 2021-03-24

1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

TerminatedNCT04493320

New York State Psychiatric InstituteCognitive Impairment, Depression, Gait Impairment

Start: 2021-02-10End: 2021-10-27Updated: 2023-05-22

Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing

TerminatedNCT04650217

New York State Psychiatric InstituteDepressive Disorder

Start: 2021-10-07End: 2021-12-31Updated: 2023-02-02

Unknown Phase

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

CompletedNCT00129181

Institute for Neurodegenerative DisordersParkinson Disease, Parkinsonian Syndrome

Start: 2005-01-31End: 2007-01-31Updated: 2009-08-28

Related Papers

Clinical Correlates of Efficacy of Pyridostigmine in the Treatment of Orthostatic Hypotension

Hypertension2024-12-275 citations

Sex-Specific Pharmacotherapy for Back Pain: A Proof-of-Concept Randomized Trial.

2021-08-1017 citations

Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension

Hypertension2021-06-2822 citations

Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension

Hypertension2016-06-0776 citations